+137.1%
BAC vs MRNA
+878.5%
-741.4%
-48.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.8% | -3.6% | +1.8% | -1.8% |
| 7D | -0.9% | -20.0% | +19.0% | -0.5% |
| 30D | -2.2% | -1.3% | -1.0% | -2.3% |
| 3M | -21.9% | +240.0% | -261.9% | -25.0% |
| 6M | +1.7% | +339.0% | -337.3% | -3.5% |
| YTD | -7.5% | +630.0% | -637.5% | -14.3% |
| 1Y | -2.8% | +769.1% | -771.9% | -10.6% |
| 3Y | +82.2% | +181.2% | -99.0% | +72.0% |
| 5Y | +20.2% | -8.1% | +28.3% | +13.8% |
| All | +137.1% | +878.5% | -741.4% | +132.1% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling